SC 13G/A: Lexaria Bioscience Corp.

AI Summary

SC 13G/A filing by Lexaria Bioscience Corp..

Risk Assessment

Risk Level: low

Filing Documents

• o10302414sc13ga3.htm (SC 13G/A) — 42KB
• 0001214659-24-019181.txt ( ) — 44KB

(a)

Item 1(a). Name of Issuer: LEXARIA BIOSCIENCE CORP.

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: #107-740 McCurdy Road Kelowna BC Canada, VIX 2P7

(a)

Item 2(a). Name of Person Filing: Invenomic Capital Management LP

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 211 Congress Street, 8 th Floor Boston, MA 02110

(c)

Item 2(c). Citizenship: Delaware, USA

(d)

Item 2(d). Title of Class of Securities: Common Shares

(e)

Item 2(e). CUSIP Number: 52886N406 Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) o Broker or dealer registered under Section 15 of the Act; (b) o Bank as defined in Section 3(a)(6) of the Act; (c) o Insurance company as defined in Section 3(a)(19) of the Act; (d) o Investment company registered under Section 8 of the Investment Company Act of 1940; (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: (b) Percent of Class: 4.7% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 567,650 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 567,650 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more tha